Literature DB >> 27277502

Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.

Michael T Osborne1,2, Edward A Hulten3, Venkatesh L Murthy4,5, Hicham Skali6, Viviany R Taqueti6, Sharmila Dorbala6, Marcelo F DiCarli6, Ron Blankstein6.   

Abstract

Although the number of clinical applications for fluorine-18 fluorodeoxyglucose (18F-FDG) cardiac positron emission tomography (PET) has continued to grow, there remains a lack of consensus regarding the ideal method of suppressing normal myocardial glucose utilization for image optimization. This review describes various patient preparation protocols that have been used as well as the success rates achieved in different studies. Collectively, the available literature supports using a high-fat, no-carbohydrate diet for at least two meals with a fast of 4-12 hours prior to 18F-FDG PET imaging and suggests that isolated fasting for less than 12 hours and supplementation with food or drink just prior to imaging should be avoided. Each institution should adopt a protocol and continuously monitor its effectiveness with a goal to achieve adequate myocardial suppression in greater than 80% of patients.

Entities:  

Keywords:  PET imaging; fluorodeoxyglucose (FDG); inflammation; metabolism

Mesh:

Substances:

Year:  2016        PMID: 27277502      PMCID: PMC5841447          DOI: 10.1007/s12350-016-0502-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  31 in total

1.  Suppression of myocardial 18F-FDG uptake with a preparatory "Atkins-style" low-carbohydrate diet.

Authors:  Richard Coulden; Peter Chung; Emer Sonnex; Quazi Ibrahim; Conor Maguire; Jon Abele
Journal:  Eur Radiol       Date:  2012-05-18       Impact factor: 5.315

2.  Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.

Authors:  J J Bax; M A Veening; F C Visser; A van Lingen; R J Heine; J H Cornel; C A Visser
Journal:  Eur J Nucl Med       Date:  1997-01

Review 3.  Glucose for the heart.

Authors:  C Depre; J L Vanoverschelde; H Taegtmeyer
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

4.  A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects.

Authors:  A C Asmal; W P Leary; F Thandroyen; J Botha; S Wattrus
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

5.  FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.

Authors:  T Mochizuki; E Tsukamoto; Y Kuge; K Kanegae; S Zhao; K Hikosaka; M Hosokawa; M Kohanawa; N Tamaki
Journal:  J Nucl Med       Date:  2001-10       Impact factor: 10.057

Review 6.  Influence of free fatty acids on myocardial oxygen consumption and ischemic injury.

Authors:  H Vik-Mo; O D Mjøs
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

7.  Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging.

Authors:  Asbjørn M Scholtens; Hein J Verberne; Ricardo P J Budde; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2015-12-10       Impact factor: 10.057

8.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Authors:  Ron Blankstein; Michael Osborne; Masanao Naya; Alfonso Waller; Chun K Kim; Venkatesh L Murthy; Pedram Kazemian; Raymond Y Kwong; Michifumi Tokuda; Hicham Skali; Robert Padera; Jon Hainer; William G Stevenson; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

9.  High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.

Authors:  S Yamada; K Kubota; R Kubota; T Ido; N Tamahashi
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

10.  The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis.

Authors:  Osamu Manabe; Keiichiro Yoshinaga; Hiroshi Ohira; Atsuro Masuda; Takahiro Sato; Ichizo Tsujino; Asuka Yamada; Noriko Oyama-Manabe; Kenji Hirata; Masaharu Nishimura; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2015-08-05       Impact factor: 5.952

View more
  50 in total

1.  Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.

Authors:  Paco E Bravo; Amitoj Singh; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2018-11-02       Impact factor: 5.952

2.  Characterization of a highly effective preparation for suppression of myocardial glucose utilization.

Authors:  Sophia R Larson; Justin A Pieper; Edward A Hulten; Edward P Ficaro; James R Corbett; Venkatesh L Murthy; Richard L Weinberg
Journal:  J Nucl Cardiol       Date:  2019-06-24       Impact factor: 5.952

Review 3.  Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.

Authors:  Mark G MacAskill; David E Newby; Adriana A S Tavares
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

4.  Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis.

Authors:  Maryam Mahmood; Ayse Tuba Kendi; Saira Ajmal; Saira Farid; John C O'Horo; Panithaya Chareonthaitawee; Larry M Baddour; M Rizwan Sohail
Journal:  J Nucl Cardiol       Date:  2017-10-30       Impact factor: 5.952

5.  Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.

Authors:  Isabelle Amigues; Aylin Tugcu; Cesare Russo; Jon T Giles; Rachelle Morgenstein; Afshin Zartoshti; Christian Schulze; Raul Flores; Sabahat Bokhari; Joan M Bathon
Journal:  Arthritis Rheumatol       Date:  2019-02-28       Impact factor: 10.995

Review 6.  Role of Imaging in Evaluating Infiltrative Heart Disease.

Authors:  Sanjay Divakaran; Avinainder Singh; Bradley Collins; Tomas Vita; Rodney H Falk; Marcelo F Di Carli; Ron Blankstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

7.  Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis.

Authors:  Sanjay Divakaran; Garrick C Stewart; Neal K Lakdawala; Robert F Padera; Wunan Zhou; Akshay S Desai; Michael M Givertz; Mandeep R Mehra; Raymond Y Kwong; Sandeep S Hedgire; Brian B Ghoshhajra; Viviany R Taqueti; Hicham Skali; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Circ Cardiovasc Imaging       Date:  2019-06-10       Impact factor: 7.792

8.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

9.  Quantification of FDG uptake in patients with a suspicion of prosthetic valve endocarditis: Part of the problem or part of the solution?

Authors:  Fabien Hyafil; François Rouzet; Dominique Le Guludec
Journal:  J Nucl Cardiol       Date:  2017-07-24       Impact factor: 5.952

10.  Optimizing myocardial metabolism for fluorine-18 fluorodeoxyglucose positron emission tomography imaging of cardiac inflammation.

Authors:  Efstathia Andrikopoulou; Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.